^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    losartan/ hydrochlorothiazide

    Company:
    Generic mfg.
    Drug class:
    Angiotensin receptor antagonist
    1year
    Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients (clinicaltrials.gov)
    P4, N=180, Completed, Shanghai Jiao Tong University School of Medicine | Recruiting --> Completed | N=300 --> 180 | Trial completion date: May 2024 --> Aug 2024 | Trial primary completion date: May 2024 --> Aug 2024
    Trial completion • Enrollment change • Trial completion date • Trial primary completion date
    |
    losartan/ hydrochlorothiazide
    almost2years
    EDUCATION FROM DERMATOLOGISTS: THE SIMULTANEOUSLY DEVELOPMENT OF 16 KERATINOCYTIC CANCERS AFTER USE OF METFORMIN IN COMBINATION WITH LOSARTAN/ HYDROCHLOROTHIAZIDE, METOPROLOL AND NIFEDIPINE- IMPORTANT LINKS TO DRUG RELATED (PHOTO)-NITROSO-CARCINOGENESIS AND ONCOPHARMACOGENESIS. (PubMed, Georgian Med News)
    The localization of the tumors in the area of the UV-exposed sites within the potential/actual contamination of the 4 preparations (simultaneously) in the described patient are indicative of a possible pathogenetic influence in the context of the already mentioned Nitroso-(Photo)carcinogenesis. Polycontamination of polymedication remains a so far unresolvable problem.
    Journal • Combination therapy
    |
    RAS (Rat Sarcoma Virus)
    |
    TP53 mutation
    |
    metformin • losartan/ hydrochlorothiazide
    2years
    Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension (clinicaltrials.gov)
    P3, N=190, Completed, Laboratorios Silanes S.A. de C.V. | Recruiting --> Completed
    Trial completion
    |
    losartan/ hydrochlorothiazide